Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chimeric Antigen Receptor T Cells (CART) Therapy in GUCY2C Positive Digestive System Tumors

NCT04780529 is registered in ClinicalTrials.gov with Innovative Cellular Therapeutics Co., Ltd. as lead sponsor.

NCT NCT04780529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04780529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chimeric Antigen Receptor T Cells (CART) Therapy in GUCY2C Positive Digestive System Tumors
Lead sponsor
Innovative Cellular Therapeutics Co., Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
March 31, 2021
Completion date
March 31, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant neoplasms of digestive organs